Chemistry and biology of antigen presentation in celiac sprue

2006 2006

Other formats: Order a copy

Abstract (summary)

Built on the previous discovery of the 33-mer gluten peptide and the revelation of the crystal structure of HLA-DQ2, this dissertation aims to explore the new avenue of blocking HLA-DQ2 mediated presentation of antigenic gluten peptides as a therapeutic option in celiac spure. First we conducted equilibrium and kinetic analysis of the binding interaction between this 33-mer peptide and recombinant DQ2, and concluded that the remarkable antigenicity of the deamidated 33-mer peptide is primarily due to its unusually efficient ability to displace existing ligands in the HLA-DQ2 binding pocket. Secondly, an N-methylation scan in conjunction with proline-to-norvaline displacement scan allowed us to explore the unusual main chain hydrogen bonding interactions in the binding of gluten peptides to HLA-DQ2. Thirdly , a systematical investigation of the structure-activity-relationship of the binding of the 33-mer peptide to DQ2 led to the discovery of a 20-mer peptide as the core binding sequence. Chemical modifications of this lead peptide yielded blocking agents which were able to attenuate the proliferation of disease-specific T cell lines in response to gluten antigens using fixed antigen presenting B cells. Next, in an attempt to optimize the effect of the blockers, we systematically synthesized a series of cyclic peptides and dimeric peptides and explored their binding affinities to HLA-DQ2 as well as their capacities to block DQ2-mediated antigen presentation. Furthermore, by quantifying the amount of DQ2 proteins expressed on the surface of DQ2+ B cells and the amount of antigen presented per cell at saturation by chemical methods, we observed a very low occupancy percentage of DQ2 on the surface of B cells even by high affinity antigens. Lastly, we explored the possibility of synthesizing reversible covalent antigen/antagonist to DQ2 in order to gain increased surface presentation hence the better inhibitory effect. Some aldehyde-containing peptide analogues can form covalent linkage with Lysβ71 of DQ2. Given the promising effect of some DQ2 blocking agents, our research provides a foundation for further research toward a therapeutic option to celiac sprue.

Indexing (details)

Organic chemistry;
0490: Organic chemistry
0571: Pathology
0982: Immunology
Identifier / keyword
Health and environmental sciences; Pure sciences; Antigen presentation; Celiac sprue
Chemistry and biology of antigen presentation in celiac sprue
Xia, Jiang
Number of pages
Publication year
Degree date
School code
DAI-B 67/11, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
Khosla, Chaitan
Stanford University
University location
United States -- California
Source type
Dissertations & Theses
Document type
Dissertation/thesis number
ProQuest document ID
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.